Biotech Stocks Reviews
- Call Transcript: Travere (TVTX) Phase 3 FILSPARI in IgA Nephropathy
Thu, Sep 21
Operator Good day, and welcome to the Travere Therapeutics Corporate Update Call. Todays conference call · more » - Call Transcript: LYRA Phase 2 in Chronic Rhinosinusitis
Tue, Sep 12
Operator Thank you. Good morning. Welcome to Lyra Therapeutics conference call and webcast to discuss · more » - GLP-1: Buy the hype, but don’t be fooled by it
Fri, Sep 8
In a priornote, we shared how weight-loss drugs might impact obesity related markets. The hype craze has · more » - Trascript: DexCom (DXCM) at Wells Fargo Healthcare Conference 2023
Thu, Sep 7
Larry Biegelsen Good afternoon. Im Larry Biegelsen, the medical device analyst at Wells Fargo. And its · more » - Call Transcript: CymaBay (CBAY) Seladelpar in Phase 3 for Primary Biliary Cholangitis
Thu, Sep 7
Operator Good day, ladies and gentlemen, and thank you for joining CymaBays Phase III RESPONSE trial top · more » - Transcript of Corvus (CRVS) Discussing Phase 3 Protocol in PTCL
Thu, Sep 7
Operator Good morning, everyone. Thank you for standing by, and welcome to the Corvus Pharmaceuticals · more » - Transcript of Insmed (INSM) Phase 3 Call in Lung Infection Caused by MAC
Tue, Sep 5
Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I · more » - Transcript of Call: Zevra (ZVRA) Acquisition of Acer (ACER)
Thu, Aug 31
Operator Good morning, everyone, and thank you for joining the Zevra Therapeutics Corporate Update Call · more » - Obesity Drugs’ Bearing on Related Markets
Wed, Aug 30
GLP-1, initially touted as a therapy for diabetes, have proven successful for weight loss, CV event · more »